Science Explorer Interactive view Map
Company · Lund · Sweden

Immunovia (Sweden)

Research works
6
▲ 5% vs 2013–17
Citations
46
7.2 per fractional work
Top-10% rate
25.5%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Immunovia (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Immunovia (Sweden) publish most on?

By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Cancer Genomics and Diagnostics and Diet and metabolism studies.

  1. 1 Pancreatic and Hepatic Oncology Research Oncology 2 works
  2. 2 Pancreatitis Pathology and Treatment Surgery 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Diet and metabolism studies Physiology 0 works
  5. 5 Adipose Tissue and Metabolism Physiology 0 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  7. 7 Immunotherapy and Immune Responses Immunology 0 works
  8. 8 Lung Cancer Research Studies Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.6%not open49.4%

World: 28% of research is openly available.

with international co-authors48.8%domestic only51.2%

World: 19% is written across borders.

How has Immunovia (Sweden)'s research output changed?

Output in 2018–2022 was 5% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lund

All research institutions in Lund

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.